AU2001232201A1 - Pharmaceutical compositions and methods for treating rheumatoid arthritis - Google Patents

Pharmaceutical compositions and methods for treating rheumatoid arthritis

Info

Publication number
AU2001232201A1
AU2001232201A1 AU2001232201A AU3220101A AU2001232201A1 AU 2001232201 A1 AU2001232201 A1 AU 2001232201A1 AU 2001232201 A AU2001232201 A AU 2001232201A AU 3220101 A AU3220101 A AU 3220101A AU 2001232201 A1 AU2001232201 A1 AU 2001232201A1
Authority
AU
Australia
Prior art keywords
methods
pharmaceutical compositions
rheumatoid arthritis
treating rheumatoid
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232201A
Inventor
Nathan Karin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technion Research and Development Foundation Ltd
Original Assignee
Technion Research and Development Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Research and Development Foundation Ltd filed Critical Technion Research and Development Foundation Ltd
Publication of AU2001232201A1 publication Critical patent/AU2001232201A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
AU2001232201A 2000-02-07 2001-02-05 Pharmaceutical compositions and methods for treating rheumatoid arthritis Abandoned AU2001232201A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09498625 2000-02-07
US09/498,625 US6420346B1 (en) 2000-02-07 2000-02-07 Polynucleotides encoding MIP-1α, MCP-1, MIP-1β, Rantes and TNF-α, and methods for treating rheumatoid arthritis
PCT/IL2001/000117 WO2001057056A1 (en) 2000-02-07 2001-02-05 Pharmaceutical compositions and methods for treating rheumatoid arthritis

Publications (1)

Publication Number Publication Date
AU2001232201A1 true AU2001232201A1 (en) 2001-08-14

Family

ID=23981837

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232201A Abandoned AU2001232201A1 (en) 2000-02-07 2001-02-05 Pharmaceutical compositions and methods for treating rheumatoid arthritis

Country Status (4)

Country Link
US (2) US6420346B1 (en)
EP (1) EP1255765A4 (en)
AU (1) AU2001232201A1 (en)
WO (1) WO2001057056A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420346B1 (en) * 2000-02-07 2002-07-16 Rappaport Family Institute For Research In The Medical Sciences Polynucleotides encoding MIP-1α, MCP-1, MIP-1β, Rantes and TNF-α, and methods for treating rheumatoid arthritis
US6818406B2 (en) * 2001-03-23 2004-11-16 Mayo Foundation For Medical Education And Research Rheumatoid arthritis markers
US7176278B2 (en) * 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
IL160289A0 (en) * 2001-08-30 2004-07-25 Biorexis Pharmaceutical Corp Modified transferrin fusion proteins
US20030226155A1 (en) * 2001-08-30 2003-12-04 Biorexis Pharmaceutical Corporation Modified transferrin-antibody fusion proteins
US20070031440A1 (en) * 2001-08-30 2007-02-08 Prior Christopher P Modified transferin-antibody fusion proteins
US8129504B2 (en) 2001-08-30 2012-03-06 Biorexis Technology, Inc. Oral delivery of modified transferrin fusion proteins
JP2003164289A (en) * 2001-11-30 2003-06-10 Seikagaku Kogyo Co Ltd Gene for bone tissue introduction
FR2838444B1 (en) * 2002-04-10 2016-01-01 Neovacs NEW PEPTIDES AND THEIR THERAPEUTIC APPLICATION
WO2003096967A2 (en) 2002-05-21 2003-11-27 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
EP1545595B1 (en) * 2002-08-30 2010-07-07 Biorexis Pharmaceutical Corporation Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
US20060105387A1 (en) * 2002-08-30 2006-05-18 Prior Christopher P Transferrin fusion proteins libraries
ATE527278T1 (en) 2002-12-16 2011-10-15 Genmab As HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)
US20070060512A1 (en) * 2003-03-04 2007-03-15 Homayoun Sadeghi Dipeptidyl-peptidase protected protein
WO2004080273A2 (en) * 2003-03-12 2004-09-23 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating prostate cancer
US8017113B2 (en) 2003-03-12 2011-09-13 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating an inflammation
WO2005021579A2 (en) * 2003-08-28 2005-03-10 Biorexis Pharmaceutical Corporation Epo mimetic peptides and fusion proteins
US20060205037A1 (en) * 2003-08-28 2006-09-14 Homayoun Sadeghi Modified transferrin fusion proteins
US9078843B2 (en) 2005-09-22 2015-07-14 Irun R. Cohen Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
EP2046826B1 (en) 2006-07-24 2011-09-14 Biorexis Pharmaceutical Corporation Exendin fusion proteins
EP2185719B1 (en) * 2007-08-02 2013-11-13 NovImmune SA Anti-rantes antibodies and methods of use thereof
AU2010286516B2 (en) * 2009-08-28 2016-10-06 Regeneron Pharmaceuticals, Inc. Antikine antibodies that bind to multiple CC chemokines
CN111770936A (en) 2018-01-12 2020-10-13 百时美施贵宝公司 Combination therapy of anti-IL-8 and anti-PD-1 antibodies for the treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3434280A (en) * 1967-11-20 1969-03-25 Joe H Burkhart Exhaust chamber
CA1153699A (en) * 1977-07-01 1983-09-13 Shinichi Tamba Exhaust system for a two-cycle engine
US5888511A (en) * 1993-02-26 1999-03-30 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS
US6316420B1 (en) * 1998-07-28 2001-11-13 Technion Research And Development Foundation Ltd. DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis
US6420346B1 (en) * 2000-02-07 2002-07-16 Rappaport Family Institute For Research In The Medical Sciences Polynucleotides encoding MIP-1α, MCP-1, MIP-1β, Rantes and TNF-α, and methods for treating rheumatoid arthritis
JP2005503320A (en) * 2000-08-25 2005-02-03 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド Methods for treating or preventing autoimmune diseases with CpG-containing polynucleotides
US20040052790A1 (en) * 2002-09-18 2004-03-18 Advanced Biotherapy, Inc. Treatment of schizophrenia

Also Published As

Publication number Publication date
WO2001057056A1 (en) 2001-08-09
US20040086483A1 (en) 2004-05-06
EP1255765A1 (en) 2002-11-13
US6420346B1 (en) 2002-07-16
EP1255765A4 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
AU2001232201A1 (en) Pharmaceutical compositions and methods for treating rheumatoid arthritis
AU2002230997A1 (en) Methods and compositions for diagnosing and treating rheumatoid arthritis
AU2001245437A1 (en) Lightweight methods and compositions for well treating
EP1635871A4 (en) Methods and compositions for treating rheumatoid arthritis
AU2001246850A1 (en) Diagnostics and remedies for rheumatoid arthritis
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU5089400A (en) Arthritis treatment
HU0103078D0 (en) Pharmaceutical compositions and methods for treating cataracts
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2002332598A1 (en) Compositions and methods for generating antigen-binding units
PL365602A1 (en) Pharmaceutical compositions and methods for use
AU9592698A (en) Methods and compositions for treating rheumatoid arthritis
AU2001285429A1 (en) High throughput screen for inhibitors of the folate biosynthetic pathway in bacteria
AU2001233932A1 (en) Method and composition
AU2002214262A1 (en) Apparatus for imparting protrusions and recesses and product
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU2001279194A1 (en) Methods and apparatus for producing granular compositions
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001249704A1 (en) Structures useful for bone engineering and methods
AU2001283226A1 (en) Methods and compositions for inhibiting rad51